Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cantor Fitzgerald analyst Li Watsek reiterates Arvinas (NASDAQ:ARVN) with a Overweight.
HC Wainwright & Co. analyst Andrew Fein reiterates Arvinas (NASDAQ:ARVN) with a Buy and maintains $87 price target.
Wedbush analyst Robert Driscoll reiterates Arvinas (NASDAQ:ARVN) with a Outperform and maintains $57 price target.
Cantor Fitzgerald analyst Li Watsek reiterates Arvinas (NASDAQ:ARVN) with a Overweight.
Barclays analyst Peter Lawson maintains Arvinas (NASDAQ:ARVN) with a Overweight and lowers the price target from $60 to $48.
Oppenheimer analyst Matthew Biegler maintains Arvinas (NASDAQ:ARVN) with a Outperform and lowers the price target from $70 t...
